IRIS
SEBASTIANI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 6.012
NA - Nord America 2.277
SA - Sud America 1.560
EU - Europa 1.146
AF - Africa 449
OC - Oceania 6
AN - Antartide 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 11.453
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 3.524
US - Stati Uniti d'America 2.147
BR - Brasile 1.239
HK - Hong Kong 750
CN - Cina 685
VN - Vietnam 646
NL - Olanda 341
ZA - Sudafrica 340
IT - Italia 282
RU - Federazione Russa 146
AR - Argentina 115
BD - Bangladesh 75
EC - Ecuador 71
DE - Germania 68
GB - Regno Unito 62
IN - India 53
IQ - Iraq 50
MX - Messico 49
CA - Canada 43
CO - Colombia 38
PL - Polonia 36
AT - Austria 35
ID - Indonesia 33
PY - Paraguay 28
VE - Venezuela 27
JP - Giappone 24
SE - Svezia 24
IE - Irlanda 23
TR - Turchia 21
MA - Marocco 20
UA - Ucraina 20
UZ - Uzbekistan 20
KE - Kenya 19
PK - Pakistan 18
ES - Italia 17
EG - Egitto 16
FI - Finlandia 16
CL - Cile 14
MY - Malesia 14
LT - Lituania 13
TN - Tunisia 13
IR - Iran 12
PE - Perù 11
UY - Uruguay 11
AE - Emirati Arabi Uniti 10
DZ - Algeria 10
CH - Svizzera 9
CR - Costa Rica 9
FR - Francia 9
JO - Giordania 9
ET - Etiopia 8
BG - Bulgaria 6
NP - Nepal 6
SA - Arabia Saudita 6
AZ - Azerbaigian 5
BA - Bosnia-Erzegovina 5
BO - Bolivia 5
CI - Costa d'Avorio 5
DO - Repubblica Dominicana 5
IL - Israele 5
JM - Giamaica 5
RO - Romania 5
AU - Australia 4
BH - Bahrain 4
GR - Grecia 4
HN - Honduras 4
KZ - Kazakistan 4
LB - Libano 4
NI - Nicaragua 4
OM - Oman 4
PS - Palestinian Territory 4
SN - Senegal 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
AL - Albania 3
BE - Belgio 3
GH - Ghana 3
HR - Croazia 3
KW - Kuwait 3
PA - Panama 3
PH - Filippine 3
PT - Portogallo 3
RS - Serbia 3
TL - Timor Orientale 3
AF - Afghanistan, Repubblica islamica di 2
AQ - Antartide 2
GA - Gabon 2
GE - Georgia 2
GT - Guatemala 2
KR - Corea 2
MK - Macedonia 2
MT - Malta 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BJ - Benin 1
BW - Botswana 1
CD - Congo 1
CY - Cipro 1
Totale 11.434
Salva come PNG Salva come JPEG
Città #
Singapore 1.541
Hong Kong 736
Dallas 339
Santa Clara 335
Johannesburg 318
Boardman 314
Ashburn 245
Ho Chi Minh City 237
Beijing 179
Hanoi 139
Moscow 118
São Paulo 106
Los Angeles 103
Buffalo 60
Columbus 59
Milan 40
Hefei 36
New York 33
Nuremberg 33
Brooklyn 31
Rio de Janeiro 31
Belo Horizonte 29
Warsaw 27
Haiphong 25
Shanghai 25
Brasília 24
Quito 24
Rome 24
Dublin 23
Da Nang 22
Guangzhou 21
Munich 21
Assago 20
Biên Hòa 20
Guayaquil 19
Curitiba 18
Tashkent 18
Baghdad 17
Stockholm 17
Vienna 17
Hải Dương 16
Thái Bình 16
Fortaleza 15
Mexico City 15
San Francisco 15
Tokyo 15
Asunción 14
Chennai 14
Dhaka 14
Guarulhos 14
Manaus 14
Montreal 14
Nairobi 14
Secaucus 14
Boston 13
Campinas 13
Chicago 13
Phoenix 13
Porto Alegre 13
Salvador 13
Toronto 12
Chandler 11
Kuala Lumpur 11
London 11
Turku 11
Atlanta 10
Buenos Aires 10
Recife 10
Shijiazhuang 10
Amman 9
Bogotá 9
Cape Town 9
Erbil 9
Goiânia 9
Lấp Vò 9
Montevideo 9
Parma 9
Santo André 9
Turin 9
Addis Ababa 8
Amsterdam 8
Bắc Ninh 8
Can Tho 8
Charlotte 8
Council Bluffs 8
Florianópolis 8
Ha Long 8
Maceió 8
Medellín 8
Montes Claros 8
Ninh Bình 8
Poplar 8
San Jose 8
Sumaré 8
Viamão 8
Zhengzhou 8
Ankara 7
Bắc Giang 7
Canoas 7
Caracas 7
Totale 6.076
Salva come PNG Salva come JPEG
Nome #
Updated systematic literature review and meta-analysis to inform the Italian Society of Rheumatology Recommendations on the treatment of rheumatoid arthritis-associated interstitial lung disease 91
Interstitial lung disease in Sjögren's syndrome: a clinical review 78
PREVALENCE, INCIDENCE AND SURVIVAL IN INTERSTITIAL LUNG DISEASE SECONDARY TO PRIMARY SJOGREN'S SYNDROME. RESULTS FROM THE "EMERGE" LONGITUDINAL STUDY 66
Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications 66
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 63
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 62
Factors associated of long-term retention rate of Janus kinase inhibitors in a multi-failure rheumatoid arthritis population 62
Clinical and Serological Characteristics of Sjogren's Disease-related Lymphocytic Interstitial Pneumonia: A Large Multicenter Study 61
CAPILLAROSCOPIC SKIN ULCER RISK INDEX (CSURI) IN SYSTEMIC SCLEROSIS: RESULTS FROM AN ITALIAN MULTICENTER VALIDATION STUDY 61
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 60
A new chance to treat rheumatoid arthritis lung fibrosis? 59
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 59
Nintedanib in Rheumatoid Arthritis-Related Interstitial Lung Disease: Real-World Safety Profile and Risk of Side Effects and Discontinuation 59
Procedural pain management in the treatment of scleroderma digital ulcers 59
Anti-TNF Therapy Is Not Associated with an Increase in Neoplasias in Patients with Spondyloarthritis (SpA): Results from the GISEA Registry 58
The impact of multimorbidity on Quality of Life in inflammatory myopathies: A cluster analysis from the COVAD dataset 58
Lung complications of Sjogren syndrome 57
2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases 56
REAL-WORLD EFFECTIVENESS OF UPADACITINIB ACROSS DIFFERENT CLINICAL PHENOTYPES IN A LARGE ITALIAN PSA COHORT 55
Aortic pulse wave velocity measurement in systemic sclerosis patients 55
Retention rate of biologic and targeted synthetic anti-rheumatic drugs in elderly rheumatoid arthritis patients: data from GISEA registry 55
Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin 55
PROGRESSIVE MICROVASCULAR ABNORMALITIES DETECTABLE OVERTIME BY NAILFOLD VIDEOCAPILLAROSCOPY IN LONG-COVID PATIENTS: A MULTICENTER ITALIAN INVESTIGATION 54
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 54
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 53
RADIOMICS AND MACHINE LEARNING FOR DIFFERENTIATING RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE AND IDIOPATHIC PULMONARY FIBROSIS WITH USUAL INTERSTITIAL PNEUMONIA PATTERN 53
AB0624 SAFETY OF RITUXIMAB BIOSIMILAR FOR THE TREATMENT OF CRYOGLOBULINEMIC VASCULITIS 53
COVID-19 vaccination-related delayed adverse events among people with rheumatoid arthritis: results from the international COVAD survey 52
Guiding ILD management in systemic autoimmune rheumatic diseases 52
A modified Delphi exercise in physician-perceived risk factors for drug-induced pneumotoxicity in patients with rheumatological disease 52
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys 52
AN OVERVIEW OF NAILFOLD CAPILLAROSCOPY IN ITALY: RESULTS FROM A NATIONAL SURVEY 52
Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection 52
Pulmonary Progressive Fibrosis in Rheumatoid Arthritis and Primary Sjogren Syndrome: Similarities and Differences 51
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 51
Disease burden in inflammatory arthritis: an unsupervised machine learning approach of the COVAD-2 e-survey dataset 50
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 50
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients 50
SEX-BASED DIFFERENCES IN 24-MONTH TREATMENT OUTCOMES WITH B/TS-DMARDS IN PSORIATIC ARTHRITIS: REAL-WORLD EVIDENCE AND PREDICTIVE MODELING FROM THE GRUPPO ITALIANO STUDIO EARLY ARTHRITIS (GISEA) MULTICENTER PROSPECTIVE REGISTRY 49
Rheumatoid arthritis related interstitial lung disease 49
Rheumatoid arthritis extra-articular lung disease: new insights on pathogenesis and experimental drugs 48
RADIOLOGIC AND SEROLOGIC FEATURES IN PATIENTS WITH INTERSTITIAL LUNG DISEASE SECONDARYTO SJOGREN'S SYNDROME. COLLABORATIVE STUDY OF ISLAND (ITALIAN STUDY GROUP ON LUNG INVOLVEMENT IN RHEUMATIC DISEASES) AND GRISS (GRUPPO DI RICERCA ITALIANO SULLA SINDROME DI SJÖGREN) STUDY GROUP OF SIR (ITALIAN SOCIETY OF RHEUMATOLOGY) 48
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 48
Progression and prognosis of interstitial pneumonia with autoimmune features: a longitudinal, prospective, multi-centre study 48
Anti-TNF Therapy Is Associated with an Increase in Serious Infections in Patients with Spondyloarthritis (SpA), Especially during the First 12 Monts of Treatment: Results from the GISEA Registry 47
Recommendations for managing the manifestations of severe and life-threatening mixed cryoglobulinemia syndrome 47
Sindrome di Sjogren primitiva: descrizione clinica e sierologica di una casistica monocentrica 47
Methotrexate and rheumatoid arthritis associated interstitial lung disease 47
Elevated Troponin Serum Levels in Adult Onset Still's Disease 47
Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey 47
Trattamento con IgIV ad alte dosi in un caso di dermatomiosite con grave disfagia refrattaria alle terapie standard 46
Diagnosis and treatment of rheumatoid arthritis in the Emilia Romagna region: a prospective population-based study 46
Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease 46
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 46
B-cells and mixed cryoglobulinemia 45
La capillaroscopia in reumatologia. Lesioni elementari e metodi di scoring 45
Axial Spondyloarthritis: Reshape the Future—From the “2022 GISEA International Symposium” 45
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature 45
AB1310 UTILIZATION AND ATTITUDES TOWARDS NAILFOLD VIDEOCAPILLAROSCOPY FOR THE ASSESSMENT OF MICROVASCULAR STATUS IN PATIENTS WITH LONG-COVID: A MULTICENTER ONLINE SURVEY 45
Rate of serious infections in spondyloarthropathy patients treated with anti-tumour necrosis factor drugs: a survey from the Italian registry GISEA 45
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 45
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 45
Inibitori biologici del TNF alfa nella terapia dell’arterite di Takayasu 45
Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG Symposium 44
Lung and Breast Cancer in Systemic Sclerosis: Correlations with the Disease's Features 44
Cardiac Involvement in Systemic Vasculitis 44
Comorbidities in the Spondyloarthritis GISEA Cohort: an average treatment effect analysis on patients treated with bDMARDs 43
COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group 43
Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease 43
Interstitial lung disease in ANCA-associated vasculitis: another step forward 43
COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study 43
Acute exacerbation of interstitial lung disease associated with rheumatic disease 43
Predictive Value of DLCO Reduction in Scleroderma Patients Without Cardio-Pulmonary Involvement at Baseline 43
Management of psoriatic arthritis: a consensus opinion by expert rheumatologists 43
Functional Progression in Patients with Interstitial Lung Disease Resulted Positive to Antisynthetase Antibodies: A Multicenter, Retrospective Analysis 43
PROPOSAL OF CORE OUTCOME DOMAINS IN MIXED CRYOGLOBULINEMIC VASCULITIS 43
Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC) 42
Micro and nanoparticles as possible pathogenetic co-factors in mixed cryoglobulinemia 42
Determinants of physical function, as measured using PROMIS PF-10a, in patients with rheumatoid arthritis: results from the international COVID-19 Vaccination in Autoimmune Diseases (COVAD) study 42
THU0289 PERSISTENCE OF CIRCULATING CRYOGLOBULINS AND RELATED SYMPTOMS AFTER HEPATITIS C VIRUS ERADICATION IN PATIENTS WITH MIXED CRYOGLOBULIN SYNDROME 42
Interstitial Lung Disease Associated With Autoimmune Rheumatic Diseases: Checklists for Clinical Practice 42
Nailfold videocapillaroscopy in antisynthetase syndrome 42
Caratteristiche demografiche, clinico-sierologiche e terapeutiche di una casistica di 133 malati italiani affetti da crioglobulinemia mista 42
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications 41
COVID-19 vaccination in autoimmune diseases (COVAD) study: Vaccine safety and tolerance in rheumatoid arthritis 41
Intracranial Stenosis Treated with Stenting in Patients with Suspected Cerebral Vasculitis: Two Case Reports 41
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature 41
Prevalenza delle epatiti nelle malattie reumatiche 41
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA Registry 41
Trattamento del dolore in reumatologia con oppioidi: nostra esperienza con ossicodone in pazienti con ulcere cutanee vasculitiche 41
Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care 41
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2 41
PRESCRIPTION PATTERN OF JAK INHIBITORS OVER 5 YEARS IN ITALY: DATA FROM THE ITALIAN NATIONAL GISEA REGISTRY 41
Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study 41
Pre-processing techniques to enhance the classification of lung sounds based on deep learning 40
Autologous skin grafting in the treatment of severe scleroderma cutaneous ulcers: a case report 40
Eritema nodoso 40
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 40
Therapeutic Strategies and Survival in Patients with Interstitial Pneumonia with Autoimmune Features 40
Clinical Characteristics of Anti-Synthetase Syndrome: Analysis from the CLASS project 40
Totale 4.894
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.823
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.823
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 4 0 1 4 1 0 0
2021/202215 0 0 0 0 4 0 1 2 0 0 1 7
2022/202343 6 2 2 3 2 7 0 3 15 2 1 0
2023/2024724 5 3 0 0 2 5 0 0 3 337 103 266
2024/20254.669 52 369 322 49 419 293 144 130 708 654 312 1.217
2025/20266.417 752 1.323 1.646 1.037 1.527 132 0 0 0 0 0 0
Totale 11.879